🫵 Are YOU familiar with the "5 Tips to Manage Polypharmacy" Toolkit developed in collaboration between deprescribing.org, ISMP Canada, and Canada's Drug Agency? Our 1st Tip for Healthcare Providers: 1️⃣ "𝐃𝐨𝐜𝐮𝐦𝐞𝐧𝐭 𝐭𝐡𝐞 𝐑𝐞𝐚𝐬𝐨𝐧 𝐟𝐨𝐫 𝐔𝐬𝐞 𝐖𝐡𝐞𝐧 𝐏𝐫𝐞𝐬𝐜𝐫𝐢𝐛𝐢𝐧𝐠 𝐚 𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧" Learn more: buff.ly/ymPDevm

A recent study calibrating the findings from the OPTiMISE trial to better reflect a representative primary care population (⬆️ Frailty, ⬆️ Co-morbidities) finds deprescribing one antihypertensive drug did NOT result in increased risk of hospitalization, or increased risk of death: buff.ly/GCgu2Ke

Effect of antihypertensive medication reduction on short-term blood pressure control in older adults: calibration of OPTiMISE trial results to real-world primary care data

AbstractBackground. While antihypertensive treatment prevents cardiovascular events, it may also increase risks such as falls in patients with frailty. The

academic.oup.com

🌿 A recent editorial explores the concept of an "Ecoprescription": "Prescribing a medication that has a lower environmental impact while ensuring similar quality and security for the patient." Learn about the environmental benefits for reducing inappropriate #polypharmacy: buff.ly/C3S59jd

Be sure to check out Canada's Drug Agency's new report, "Appropriate Use of Medications in Hospital Settings" which examines medication use and prescribing patterns across 115 acute care hospitals in Canada! 🇨🇦 Find both the Plain Language Summary and Full Report here: lnkd.in/guBTYb25

Thanks @cbcradiocanada.bsky.social & Dr. Gary Rodin for highlighting the challenges of #Deprescribing #Antidepressants on "Ontario Today"! 🇨🇦 It's important to hear the perspectives of patients and their lived experience of taking medications. 🔊👂 Listen to the full program here: buff.ly/B95Zi83

🫀 Great to see the @americanheart.bsky.social's New Scientific Statement on "Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy"! Happy to see #Deprescribing being acknowledged as a key pillar of Person-Centered Care in this population. Read more: buff.ly/sUKgQg6

🚨 Published in the Journal of the American Geriatrics Society, an Umbrella Review of Systematic Reviews looking at interventions to optimize medication management in older adults summarizes evidence from over 1.5 million cumulative participants. Read the full article here: buff.ly/Z7l913r

A Systematic Review of Economic Evaluations of #Deprescribing Interventions provides helpful context on the economic value of deprescribing! 💵 Read the full article below for more insights: buff.ly/AO5Y1iF

A cohort study published in @jamanetworkopen.com found approximately 16% of medications deprescribed in a hospital setting were restarted at 90 days after discharge from a post-acute inpatient rehabilitation facility. Read about the influencing factors in the full article below: buff.ly/wiNCbeQ

Check out a great read from The Lancet Healthy Longevity on rethinking how we measure success in #deprescribing research! Studies designed using a superiority framework may not always adequately capture the most relevant endpoints or clinical goals of deprescribing. Read more: buff.ly/9EgJJqA

📣 Check out @cihica.bsky.social's new refresh of their Beers Indicator, now updated with the 2023 Beers Criteria, and with data from Quebec! In 2024–2025, 42.7% of Canadian seniors were prescribed at least one medication from the Beers list. Read more here: buff.ly/gDqWXSw

Congrats to @deprescribing.bsky.social's Alexa Muir, who was awarded the CIHR Canada Graduate Research Scholarship – Doctoral (CGRS D)! This prestigious national award is valued at $120,000 over 3 years. We are thrilled & excited to see what the coming years hold for Alexa!

🏥 🌎 Healthcare systems differ worldwide, with systems from each region each having their own strengths and limitations. An insightful article published in @agsjournal.bsky.social highlights how different healthcare systems would manage key issues from the same older adult patient: buff.ly/tfStpoN

Join GeriMedRisk's Geriatric Clinical Pharmacology Rounds on June 2, 2026 from 12:00 to 1:00 PM EST! Our deprescribing.org Co-Director Dr. Wade Thompson will be presenting on, "When to Stop Statins? The New Evidence-Based Statin Deprescribing Guideline" 👉 Registration Link here: buff.ly/0EBtNc8

🎉 Check out @ontariohealth.bsky.social's new Prevention Placemats, a series of evidence-informed tools that offer practical clinical guidance and provides links to additional curated resources to help prevent "Never Events": buff.ly/Yr9VC3F Be sure to review the Medication Safety Placemats! 💊

🔥🔥 Our NEW evidence-based guideline for #Statin #Deprescribing is now posted on deprescribing.org, and will be published in @cfpjournal.bsky.social! @caden-recad.bsky.social @choosingwiselyca.bsky.social @amergeriatrics.bsky.social @canadiangeriatrics.bsky.social 👉 buff.ly/qIEvOSD (1/8)

Deprescribing.org - Optimizing Medication Use

Deprescribing.org - reducing medications safely to meet life’s changes. Online resources for clinicians and patients to help with deprescribing.

deprescribing.org

It was a pleasure hosting Drs. Fatma Karapinar, Yannick Nielen, and Veerle van Hulten from Maastricht UMC+ at @pharmacy.utoronto.ca last week! Discover more of their work on the the real-world complexity of prescribing cascades here: buff.ly/LKwXEnU

@deprescribing.bsky.social had a splendid time at the International Conference on Deprescribing (ICOD) 2026 at Montréal last week!!! It was terrific to be able to spread our #deprescribing work & contribute to the rapidly evolving deprescribing landscape! 💊

A recent publication in @cfpjournal.bsky.social highlights the use of the "ECO-Rx Framework" to reduce the environmental impact of medications while also improving patient outcomes! 💡 Read the full article including a helpful case review here: buff.ly/uAXffUX

🚨 Check out the newest publication from our deprescribing.org collaborators & team members! 🌎 Stakeholders from over 14 countries provided insights on how deprescribing guidelines are shared and used across different organizations: buff.ly/0Mhclm5 Findings: There is room for improvement!

Congrats to Kainat Bashir for representing @deprescribing.bsky.social at #ICIC26 in Birmingham, 🇬🇧! 👏 Guided by the principles of integrated care, Kainat highlighted two projects: 1️⃣ The DIAL Study 2️⃣ An Environmental Scan on Diabetes & Dementia Care for Older Immigrant Adults in Mississauga

A Cluster Randomized Clinical Trial published in @jamainternalmed.com compared the effectiveness of different PPI deprescribing interventions: buff.ly/5SjxPqv 💊 PPI dose reduction was highest in the intervention involving both patients and GPs.

📢 The International Conference on Deprescribing (ICOD) 2026 is fast approaching! Happening in Montreal Canada 🇨🇦 from April 27-29, 2026, @deprescribing.bsky.social is excited to connect with you there! For registered attendees, be sure to review the Conference Agenda located here: buff.ly/s6EEP3j

#Deprescribing interventions are often initiated in the hospital setting. 🏥 Unfortunately, interventions are not always continued after hospital discharge. A qualitative study investigates key factors impacting successful deprescribing: buff.ly/gBnz51d

Reasons Behind Continuity of In-Hospital Deprescribing Post Discharge: A Qualitative Study

Deprescribing reduces inappropriate polypharmacy in older adults and may be initiated in hospital. However, deprescribing changes initiated during a hospital admission are not always continued post…

jamda.com

A systematic review & meta-analysis compiled evidence from 15 studies investigating the effects of #deprescribing preventive medications among older adults with advanced frailty, dementia, or limited life expectancy. Read the full open-access article to learn more: buff.ly/UR63l5p

Older adults are sensitive to the adverse effects of diuretics. New systematic review in The Lancet Healthy Longevity provides helpful guidance to reassess the appropriateness of #diuretics, and to aid diuretic deprescribing when indicated. 📖 Read the full article here: buff.ly/QVauDyu

March 15 to 21, 2026 is National Poison Prevention Week in 🇨🇦! 💭 Did you know that #Medications are the leading cause of #poisoning in Canada? Learn more about how you can help prevent medication-related poisoning injuries here: buff.ly/bGL1qAw #RethinkPoisons @parachute.ca

Happy to share @adphaau.bsky.social's MedsAware Deprescribing Action Week from March 16 to 20, 2026! In an age of misinformation, health professionals play a vital role in ensuring decisions about medication use are informed, evidence-based and person-centred. Learn more: adpha.au/news-advocac...

Learn how to use MedSafer - A new free tool to support safer #deprescribing, by watching their new whiteboard video! www.youtube.com/watch?v=Xz6j... Access the MedSafer tool here: public.medsafer.org/public/reports The tool was created with support from Health Canada 🇨🇦

MedSafer: A New Tool to Support Safer Deprescribing

YouTube video by CADeN-ReCAD

youtube.com

Wednesday March 11, 2026 is World Delirium Awareness Day! Delirium is a sudden decline in mental functioning that arises over hours or days. Learn more about World Delirium Awareness Day and find helpful resources to share with friends, family, colleagues, and patients below👇 buff.ly/xjmqCET